Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pseudotumor cerebri presenting as headache.

Deborah I Friedman1

  • 1University of Rochester School of Medicine and Dentistry, 601 Elmwood Avenue, Box 659, Rochester, NY 14642, USA. deborah_friedman@urmc.rochester.edu

Expert Review of Neurotherapeutics
|March 19, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The SIH Impact Inventory: A Pilot Study of a Novel Instrument Assessing Quality of Life in Spontaneous Intracranial Hypotension.

Neurology. Clinical practice·2026
Same author

Consensus Guidelines on Diagnostic Brain and Spine Imaging of Spontaneous Intracranial Hypotension.

AJNR. American journal of neuroradiology·2025
Same author

The 2025 Scottsdale Headache Symposium: New beginnings.

Headache·2025
Same author

Telemedicine is effective and safe for clinical management of patients with headache disorders: An American Headache Society position statement.

Headache·2025
Same author

The contribution of lumbar puncture opening pressure in the diagnosis of spontaneous intracranial hypotension: A systematic literature review and meta-analysis.

Headache·2025
Same author

National Conference of Neuro-Ophthalmology in Chandigarh India February 7-9, 2025.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2025
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Pseudotumor cerebri (PTC), or idiopathic intracranial hypertension, causes disabling headaches and potential vision loss. Prompt diagnosis and management are crucial to prevent permanent visual deficits.

Area of Science:

  • Neurology
  • Ophthalmology

Background:

  • Pseudotumor cerebri (PTC) involves intracranial hypertension without a clear cause.
  • Headache is the primary symptom in over 90% of PTC cases.
  • Visual loss is a significant complication requiring timely intervention.

Purpose of the Study:

  • To review the diagnosis of PTC.
  • To discuss differential diagnoses for PTC.
  • To outline management strategies for PTC.

Main Methods:

  • Literature review of diagnostic criteria.
  • Analysis of differential diagnoses.
  • Summary of current treatment options.

Main Results:

  • PTC is defined by intracranial hypertension without other identifiable causes.

Related Experiment Videos

  • Ophthalmoscopy is essential for headache evaluation in suspected PTC.
  • Evidence-based guidelines for PTC treatment are lacking.

    • Conclusions:

    • Accurate diagnosis and prompt management are vital for preventing vision loss in PTC patients.
    • A comprehensive approach including differential diagnosis and treatment strategies is necessary.
    • Further research is needed to establish evidence-based treatment guidelines.